Decatur, GA – According to filings with the U.S. Securities and Exchange Commission, EarliTec Diagnostics is raising $19,500,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Thomas Ressemann played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About EarliTec Diagnostics
EarliTec is a digital health company focused on diagnostic and therapeutic products for children with ASD and associated developmental disabilities. By studying how children view the world in which they live, we can quantify how they perceive social interactions so that parents, providers, and caregivers know the status and severity of their disability. Our technology, developed by leading researchers from Yale and Emory Universities, is pioneering clinically validated, objective measurements to enable data-driven decisions for personalized care.

To learn more about EarliTec Diagnostics, visit http://www.earlitecdx.com/

Contact:
Thomas Ressemann, President and Chief Executive Officer
833-504-9937
https://www.linkedin.com/in/thomas-ressemann-74514743/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved